Platinum-doublet chemotherapy
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Platinum-doublet chemotherapy, covering 2021-04-21 to 2025-01-13. Get the full timeline:
Most recent: Clinical Trial Update: Platinum-doublet Chemotherapy and Nivolumab for the Treatment of Subjects With Neuroendocrine Neoplasms (NENs) of the Gastroenteropancreatic (GEP) Tract or of Unknown (UK) Origin. [Phase 2]